MiR-466 Inhibits the Progression of Severe Hepatocellular Carcinoma via Regulating FMNL2-Mediated Activation of NF-κB and Wnt/β-Catenin Pathways

Figure 1

MiR-466 significantly downregulated in HCC tissues and cell lines. (a) The relative expression levels of miR-466 in the tumor and paracancerous tissues measured by qRT-PCR. (b) The relative expression levels of miR-466 normal human liver and HCC cell lines measured by qRT-PCR. , .

(a)

(b)